Significance of the endothelin ETA receptor in the haemodynamic and inotropic effects of endothelin-1 in rats

Clinical Science

Volumn 107, Issue 5, 2004, Pages 467-475

  Beyer, Martin E ^a   Hövelborn, Tobias ^a   Delabar, Ursula ^b   Hoffmeister, Hans Martin ^a,c  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF TÜBINGEN   (Germany)

^c STÄDTISCHES KLINIKUM SOLINGEN   (Germany)

Author keywords

Adenosine; Contractile function; Endothelin; Endothelin A receptor; Haemodynamics; Heart

Indexed keywords

ADENOSINE; ADENOSINE TRIPHOSPHATE; ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; VASODILATOR AGENT; ANTIHYPERTENSIVE AGENT; OLIGOPEPTIDE; PIPERIDINE DERIVATIVE;

ANIMAL EXPERIMENT; ANIMAL MODEL; AORTA CLAMPING; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY CONSTRICTION; ENERGY METABOLISM; HEART AFTERLOAD; HEART FUNCTION; HEART MUSCLE ISCHEMIA; HEART OUTPUT; HEMODYNAMICS; INOTROPISM; MALE; MONITORING; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR UPREGULATION; VASCULAR RESISTANCE; ANIMAL; DRUG EFFECT; HEART CONTRACTION; PHYSIOLOGY; VASOCONSTRICTION; WISTAR RAT;

ANIMALS; ANTIHYPERTENSIVE AGENTS; CARDIAC OUTPUT; ENDOTHELIN-1; HEMODYNAMIC PROCESSES; MALE; MYOCARDIAL CONTRACTION; OLIGOPEPTIDES; PIPERIDINES; RATS; RATS, WISTAR; RECEPTOR, ENDOTHELIN A; VASOCONSTRICTION;

EID: 16544369439     PISSN: 01435221     EISSN: None     Source Type: Journal    
DOI: 10.1042/CS20030352     Document Type: Article

References (46)

1. Yanagisawa, M., Kurihara, H., Kimura, S. et al. (1988) A novel potent constrictor peptide produced by vascular endothelial cells. Nature (London) 332, 411-415
2. Arai, H., Hori, S., Aramori, I., Ohkubo, H. and Nakanishi, S. (1990) Cloning and expression of a cDNA encoding an endothelin receptor. Nature (London) 348, 730-732
3. Sakurai, T., Yanagisawa, M., Takuwa, Y. et al. (1990) Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature (London) 348, 732-735
4. Rodeheffer, R. J., Lerman, A., Heublein, D. M. and Burnett, J. C. (1992) Increased plasma concentrations of endothelin in congestive heart failure in humans. Mayo Clin. Proc. 67, 719-724
5. Stewart, D. J., Kubac, G., Costello, K. B. and Cernacek, P. (1991) Increased plasma endothelin-1 in the early hours of acute myocardial infarction. J. Am. Coll. Cardiol. 18, 38-43
6. Kiowski, W., Sütsch, G., Hunziker, P. et al. (1995) Evidence of endothelin-1-mediated vasoconstriction in severe chronic heart failure. Lancet 346, 732-736
7. A receptor blockade in chronic heart failure patients treated with ACE inhibitors. Circulation 94, 2131-2137
8. Krum, H., Viskoper, R. J., Lacourcière, Y., Budde, M., Charlon, V. and the Bosentan Hypertension Investigators (1998) The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. N. Engl. J. Med. 338, 784-790
9. Fukuroda, T., Nishikibe, M., Ohta, Y. et al. (1992) Analysis of responses to endothelins in isolated porcine blood vessels by using a novel endothelin antagonist, BQ-153. Life Sci. 50, PL107-PL112
10. B) mediate vasoconstriction in the perfused rat heart. J. Cardiovasc. Pharmacol. 22 (Suppl. 8), S248-S251
11. Fujitani, Y., Ueda, H., Okada, T., Urade, Y. and Karaki, H. (1993) A selective agonist of endothelin type B receptor, IRL 1620, stimulates cyclic GMP increase via nitric oxide formation in rat aorta. J. Pharmacol. Exp. Ther. 267, 683-689
12. B receptor. Br. J. Pharmacol. 109, 486-490
13. Shetty, S. S., Okada, T., Webb, R. L., del Grande, D. and Lappe, R. W. (1993) Functionally distinct endothelin B receptors in vascular endothelium and smooth muscle. Biochem. Biophys. Res. Commun. 191, 459-464
14. B receptors mediate contraction to endothelin-1 in human blood vessels. Circulation 89, 1203-1208
15. B receptors in canine coronary arteries. Circ. Res. 74, 105-114
16. B receptors in rats. Biochem. Biophys. Res. Commun. 199, 1461-1465
17. Van Renterghem, C., Vigne, P., Barhanin, J., Schmid-Alliana, A., Frelin, C. and Lazdunski, M. (1988) Molecular mechanisms of action of the vasoconstrictor peptide, endothelin. Biochem. Biophys. Res. Commun. 157, 977-985
18. 2+ store overlaps with caffeine-sensitive one in rat aortic smooth muscle cells in primary culture. Biochem. Biophys. Res. Commun. 158, 235-243
19. Wallnofer, A., Weir, S., Rüegg, U. and Cauvin, C. (1989) The mechanism of action of endothelin-1 as compared with other agonists in vascular smooth muscle. J. Cardiovasc. Pharmacol. 13 (suppl.5), S23-S31
20. + exchanger. Circ. Res. 86, 269-279
21. Hu, J. R., von Harsdorf, R. and Lang, R. E. (1988) Endothelin has potent inotropic effects in rat atria. Eur. J. Pharmacol. 158, 275-278
22. Moravec, C. S., Reynolds, E. E., Stewart, R. W. and Bond, M. (1989) Endothelin is a positive inotropic agent in human and rat heart in vitro. Biochem. Biophys. Res. Commun. 159, 14-18
23. Karwatowska-Prokopczuk, E. and Wennmalm, Å. (1990) Effects of endothelin on coronary flow, mechanical performance, oxygen uptake, and formation of purines and on outflow of prostacyclin in the isolated rabbit heart. Circ. Res. 66, 46-54
24. Neubauer, S., Ertl, G., Haas, U., Pulzer, F. and Kochsiek, K. (1990) Effects of endothelin-1 in isolated perfused rat heart. J. Cardiovasc. Pharmacol. 16, 1-8
25. Domenech, R., Macho, P., González, R. and Huidobro-Toro, J. P. (1991) Effect of endothelin on total and regional coronary resistance and on myocardial contractility. Eur. J. Pharmacol. 192, 409-416
26. Yang, X.-P., Madeddu, P., Micheletti, R. et al. (1991) Effects of intravenous endothelin on hemodynamics and cardiac contractility in conscious Milan normotensive rats. J. Cardiovasc. Pharamacol. 17, 662-669
27. Beyer, M. E., Nerz, S., Krämer, B. K. and Hoffmeister, H. M. (1994) Hemodynamic and inotropic effects of endothelin-1 in vivo. Basic Res. Cardiol. 89, 39-49
28. Beyer, M. E., Nerz, S., Kazmaier, S. and Hoffmeister, H. M. (1995) Effect of endothelin-1 and its combination with adenosine on myocardial contractility and myocardial energy metabolism in vivo. J. Mol. Cell. Cardiol. 27, 1989-1997
29. Beyer, M. E., Sleask, G., Hövelborn, T., Kazmaier, S., Nerz, S. and Hoffmeister, H. M. (1999) Inotropic effects of endothelin-1: interaction with molsidomine and with BQ 610. Hypertension 33, 145-152
30. B receptors for myocardial contractility and myocardial energy metabolism. J. Pharmacol. Exp. Ther. 278, 1228-1234
31. Ishikawa, K., Ihara, M., Noguchi, K. et al. (1994) Biochemical and pharmacological profile of a potent and selective endothelinB-receptor antagonist, BQ 788. Proc. Natl. Acad. Sci. U.S.A. 91, 4892-4896
32. Pfeffer, M. A., Pfeffer, J. M., Fishbein, M. C. et al. (1979) Myocardial infarct size and ventricular function in rats. Circ. Res. 44, 503-512
33. Goodyer, A. V. N., Goodkind, M. J. and Landry, A. B. (1962) Ventricular response to a pressure load. Left ventricular function curves in intact animals. Circ. Res. 10, 885-896
34. Delabar, U., Kloor, D., Luippold, G. and Mühlbauer, B. (1999) Simultaneous determination of adenosine, S-adenosylhomocysteine and S-adenosylmethionine in biological samples using solid-phase extraction and high-performance liquid chromatography. J. Chromatogr., B 724, 231-238
35. Clarke, J. G., Larkin, S. W., Benjamin, N. et al. (1989) Endothelin-1 is a potent and long-lasting vasoconstrictor in dog peripheral vasculature in vivo. J. Cardiovasc. Pharmacol. 13 (Suppl. 5), S211-S212
36. Chester, A. H., Dashwood, M. R., Clarke, J. G. et al. (1989) Influence of endothelin on human coronary arteries and localization of its binding sites. Am. J. Cardiol. 63, 1395-1398
37. Ricou, F. J., Murata, K., Oh, B.-H., Kambayashi, M. and Peterson, K. L. (1992) Evaluation of inotropic effect of endothelin-1 in vivo. J. Cardiovasc. Pharmacol. 20, 671-677
38. Makujina, S. R., Olanrewaju, H. A. and Mustafa, S. J. (1994) Evidence against KATP-channel involvement in adenosine receptor-mediated dilation of epicardial results. Am. J. Physiol. 267, H716-H724
39. Belardinelli, K. and Isenberg, G. (1983) Actions of adenosine and isoproterenol on isolated mammalian ventricular myocytes. Circ. Res. 53, 287-297
40. Böhm, M. (1987) Cardiac effect of adenosine: mechanism of action, pathophysiological role and clinical implications. Klin. Wochenschr. 65, 487-499
41. Hoffmeister, H. M., Betz, R., Fiechtner, H. and Seipel, L. (1987) Myocardial and circulatory effects of inosine. Cardiovasc. Res. 21, 65-71
42. A receptor subtype mediates endothelin-induced contractility in left ventricular cardiomyocytes isolated from rabbit myocardium. J. Pharmacol. Exp. Ther. 294, 1047-1052
43. Goldberg, A. T., Bond, B. R., Mukherjee, R. et al. (2000) Endothelin receptor pathway in human left ventricular myocytes: relation to contractility. Ann. Thorac. Surg. 69, 711-715
44. Pieske, B., Beyermann, B., Breu, V. et al. (1999) Functional effects of endothelin and regulation of endothelin receptors in isolated human nonfailing and failing myocardium. Circulation 99, 1802-1809
45. Dhein, S., Giessler, C., Wangemann, T., Silber, R.-E., Zerkowski, H. R. and Brodde, O.-E. (2000) Differential pattern of endothelin-1-induced inotropic effects in right atria and left ventricles of the human heart. J. Cardiovasc. Pharmacol. 36, 564-569
46. B receptors in human myocardial trabeculae. Clin. Sci. 99, 161-168